Lazard Asset Management
LCTX icon

Lazard Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Lazard Asset Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-148
Closed – – 2446
2024
Q4 		$0 Hold
148
– – ﹤0.01% 2419
2024
Q3 		$0 Sell
148
-255
-63% -$236 ﹤0.01% 2373
2024
Q2 		$0 Sell
403
-5,656
-93% -$6.25K ﹤0.01% 2346
2024
Q1 		$8K Sell
6,059
-3,356
-36% -$3.81K ﹤0.01% 1882
2023
Q4 		$10K Buy
9,415
+578
+7% +$633 ﹤0.01% 2097
2023
Q3 		$10K Buy
8,837
+457
+5% +$622 ﹤0.01% 2143
2023
Q2 		$11K Buy
8,380
+314
+4% +$434 ﹤0.01% 2176
2023
Q1 		$11K Sell
8,066
-76,575
-90% -$107K ﹤0.01% 2119
2022
Q4 		$98K Buy
84,641
+6,667
+9% +$8.4K ﹤0.01% 1543
2022
Q3 		$88K Buy
+77,974
New +$114K ﹤0.01% 1519
2022
Q1 		– Sell
-21,610
Closed -$52K – 2444
2021
Q4 		$52K Buy
+21,610
New +$50.6K ﹤0.01% 1723

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
RA
Raffles Associates New York $115M AUM 35.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return